A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting
A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting in Patients With Head and Neck Squamous Cell Carcinomas
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Listed as NCT05792228, this NA trial focuses on Chemotherapy Induced Nausea and Vomiting and Squamous Cell Carcinoma of Head and Neck and remains completed. Sponsored by Tianjin Medical University Cancer Institute and Hospital, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2023 — Dec 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2023 — May 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Tianjin Medical University Cancer Institute and Hospital
For direct contact, visit the study record on ClinicalTrials.gov .